(lp0
S"VBI Vaccines Is An Alternative To The Agenus Inc. Failure Seeking Alpha - Mar 28, 2017 In September last year I highlighted an opportunity to get into VBI and its RSV program on the back of Novavax's failure. A similar opportunity has arisen in the glioblastoma multiforme  space."
p1
aS"The Bears And Bulls Square Off On Agenus Inc.  NY Stock News - 17 hours ago Agenus Inc.  has presented a rich pool of technical data in recent sessions. These are the trends we've been tracking and how we feel they should be played in the current environment."
p2
aS'Agenus Restructures Business to Sharpen Focus on Clinical Development of ... PR Newswire  - Mar 30, 2017 LEXINGTON, Mass., March 30, 2017 /PRNewswire/ -- Agenus Inc. , an immuno-oncology company with a clinical stage pipeline of immune checkpoint antibodies and cancer vaccines, today announced that it is reorganizing its business and&nbsp;...Lexington biotech Agenus to cut 50 jobs in reorganization - Boston Business Journal'
p3
aS'Agenus to Participate at Two Upcoming Immuno-Oncology Conferences PR Newswire  - Mar 24, 2017 Agenus cautions investors not to place considerable reliance on the forward-looking statements contained in this release. These statements speak only as of the date of this press release, and Agenus undertakes no obligation to update or revise the&nbsp;...'
p4
aS'Agenus Inc.  Soars 7.1% on April 14 Equities.com - Apr 14, 2017 Agenus Inc.  had a good day on the market for Friday April 14 as shares jumped 7.1% to close at $3.47. About 2.34 million shares traded hands on 8,749 trades for the day, compared with an average daily volume of 1.17 million shares out of a total&nbsp;...Steady Stock Movements: Agenus Inc  - Post RegistrarAgenus Inc  Trading 7.1% Higher Following Insider Buying Activity - Sports Perspectives'
p5
aS'Agenus Commences Phase 1 Trial with Neoantigen Cancer Vaccine AutoSynVax PR Newswire  - Apr 5, 2017 LEXINGTON, Mass., April 5, 2017 /PRNewswire/ -- Agenus Inc. , an immuno-oncology company with a clinical stage pipeline of immune checkpoint antibodies and cancer vaccines, today announced that the first patient has been dosed in a&nbsp;...'
p6
aS'What Do Analysts Suggest For Agenus Inc.  News Oracle - 18 hours ago Many analysts are providing their Estimated Earnings analysis for Agenus Inc. and for the current quarter 4 analysts have projected that the stock could give an Average Earnings estimate of $-0.27/share.'
p7
aS'Agenus Inc.  Moves Higher on Volume Spike for April 13 Equities.com - Apr 13, 2017 Agenus Inc.  traded on unusually high volume on Apr. 13, as the stock gained 7.1% to close at $3.47. On the day, Agenus Inc. saw 2.33 million shares trade hands on 8,748 trades. Considering that the stock averages only a daily volume of 1.05 ...Insider Buying: Agenus Inc  CEO Buys 100000 Shares of Stock - The Cerbat Gem'
p8
aS"Analysts mean rating score stands at 1.80 while Agenus Inc.'s  stock ... Hot Stocks Point - 21 hours ago Agenus Inc. , a part of Healthcare sector and belongs to Biotechnology industry; ended its day with gain 7.10% and finalized at the price of $3.47."
p9
aS'Decision Time: Agenus Inc  Stock Technicals Hit Inflection Point CML News - 21 hours ago Decision Time: Agenus Inc  now sits in the perhaps the most difficult technical position -- the stock has no urgency in its direction and that has left it at an inflection point.'
p10
a.